Chimeric Infectious Bursal Disease Virus-Like Particles as Potent Vaccines for Eradication of Established HPV-16 E7–Dependent Tumors

• Juan Martin Caballero ,

  Contributed equally to this work with: Juan Martin Caballero, Ana Garzón

  Affiliation Laboratory Animal Unit, Barcelona Biomedical Research Park, Barcelona, Spain

  ⨯
• Ana Garzón ,

  Contributed equally to this work with: Juan Martin Caballero, Ana Garzón

  Current address: Azurebio S.L., Madrid, Spain

  Affiliation Cancer Vaccines Unit, R & D Department, Chimera Pharma S.L.U., Madrid, Spain

  ⨯
• Leticia González-Cintado,

  Affiliation Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain

  ⨯
• Wioleta Kowalczyk,

  Current address: CSIRO Materials Science and Engineering, Australia

  Affiliation Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Barcelona, Spain

  ⨯
• Ignacio Jimenez Torres,

  Current address: Igenbiotech, Madrid, Spain

  Affiliation Cancer Vaccines Unit, R & D Department, Chimera Pharma S.L.U., Madrid, Spain

  ⨯
• Gloria Calderita,

  Current address: Nimgenetics, Parque Científico de Madrid, Madrid, Spain

  Affiliation Cancer Vaccines Unit, R & D Department, Chimera Pharma S.L.U., Madrid, Spain

  ⨯
• Margarita Rodriguez,

  Current address: Hospital Universitario Sanchinarro, Madrid, Spain

  Affiliation Cancer Vaccines Unit, R & D Department, Chimera Pharma S.L.U., Madrid, Spain

  ⨯
• Virgínia Gondar,

  Current address: Hospital Universitario de la Princesa, Unidad de Biología Molecular, Instituto Investigación Sanitaria Princesa, Madrid, Spain

  Affiliation Cancer Vaccines Unit, R & D Department, Chimera Pharma S.L.U., Madrid, Spain

  ⨯
• Juan Jose Bernal,

  Current address: Protein Alternatives S.L., Tres Cantos, Madrid, Spain

  Affiliation Cancer Vaccines Unit, R & D Department, Chimera Pharma S.L.U., Madrid, Spain

  ⨯
• Carlos Ardavín,

  Affiliation Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Madrid, Spain

  ⨯
• David Andreu,

  Affiliation Department of Experimental and Health Sciences, Pompeu Fabra University, Barcelona Biomedical Research Park, Barcelona, Spain

  ⨯
• Thomas Zürcher,

  Current address: ForMune S.L., Vivero de Innovación, Navarra, Spain

  Affiliation Cancer Vaccines Unit, R & D Department, Chimera Pharma S.L.U., Madrid, Spain

  ⨯
• Cayetano von Kobbe

  * E-mail: cvonkobbe@cbm.uam.es

  Current address: Molecular Biology Centre “Severo Ochoa”, Spanish Research Council (CBMSO-CSIC), Universidad Autónoma de Madrid, Madrid, Spain

  Affiliation Cancer Vaccines Unit, R & D Department, Chimera Pharma S.L.U., Madrid, Spain

  ⨯